Free Trial

Intellia Therapeutics (NTLA) SEC Filings & 10K Form

Intellia Therapeutics logo
$15.43
+0.29 (+1.92%)
(As of 11/5/2024 ET)

Recent Intellia Therapeutics SEC Filings

DateFilerForm TypeView
10/25/2024
3:59 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:29 PM
Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
3:17 PM
Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:13 PM
Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
3:03 PM
Intellia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/03/2024
12:15 PM
Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
12:15 PM
Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
7:06 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
4:00 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:14 PM
Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:15 PM
Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2024
3:16 PM
CHASE WILLIAM J (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:18 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:19 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:20 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:21 PM
Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:22 PM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:25 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:40 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:16 PM
Intellia Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:10 PM
Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
3:21 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
8:26 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:04 AM
Intellia Therapeutics (Filer)
Form 424B5
02/23/2024
4:22 PM
Intellia Therapeutics (Filer)
Form 424B5
02/23/2024
4:17 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/24/2024
10:21 AM
Intellia Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:15 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/05/2024
3:44 PM
Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:45 PM
BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:46 PM
Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:49 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:50 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:50 PM
Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:51 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:28 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Election warning coming true… (Ad)

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

01/03/2024
4:30 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:34 PM
Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:35 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:09 PM
Crowley John F (Reporting)
Intellia Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
6:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
8:30 AM
Intellia Therapeutics (Filer)
Form S-3ASR
11/09/2023
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NTLA) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners